Dr. Lieberman’s article featured in the El Mundo newspaper from Madrid, Spain. Also posted on elmundo.es (October 2024) Read the article (PDF) by clicking the button below. (Please note: This PDF is in Spanish)
Healio | The inside story of Cobenfy
Learn the history of the drug ‘Cobenfy’ (formerly ‘KarXT’) and its journey to become FDA approved. Originally published on Healio.com. (October 2024) Read the published article (PDF) by clicking the button below.
TIME Magazine | The Health Hazards of Legalizing Marijuana
From TIME Magazine: Read Dr. Jeffrey Lieberman’s article discussing marijuana as a legal substance, and the pros & cons that come with it. Originally published on time.com. (June 2024) Read the published article (PDF) by clicking the button below.
Psychiatry’s Risky Gamble on Recreational Drugs: The Royal Road to the Unconscious
Read Dr. Lieberman’s (with Nico Warren) commentary on society’s view of recreational drugs – past and present. Originally published on PsychiatricTimes.com. (September 2024) Read the published article (PDF) by clicking the button below.
POTUS, Politics & Neuropsychiatric: Assessment of What We Need to Know and When
Read Dr. Lieberman’s commentary regarding the topic of politics and neuropsychiatrics and his assessment of public awareness. Originally published on PsychiatricTimes.com. (September 2024) Read the published article (PDF) by clicking the button below.
Lieberman & Kennedy: Psychedelics worth pursuing, with care
Read Dr. Jeffrey Lieberman and Senator Patrick Kennedy’s Op-Ed on psychedelics as medicinal treatment of mental disorders such as P.T.S.D. Originally published on BostonHerald.com. (June 2024) Read the published article (PDF) by clicking the button below.
LEADERS Magazine, LLC | An Interview with Jeffrey A. Lieberman, MD
An Interview with Jeffrey A. Lieberman, MD, Professor and Constance and Stephen Lieber Chair in Psychiatry, Columbia University Vagelos College of Physicians and Surgeons, featured in LEADERS Magazine, LLC (2024) Read the published article (PDF) by clicking the button below. […]
Fast Company | Wall Street is embracing the psychedelic industry—and it’s causing a culture clash
Money is pouring into the fledgling psychedelic medicine industry, with dozens of startup companies vying to be among the first to sell mind-expanding drugs for depression, addiction, and other mental health conditions. While psychedelics are still illegal under federal law, companies are […]
The People’s Pharmacy | Show 1373: Malady of the Mind
This week, our guest is one of the country’s leading experts on schizophrenia, Dr. Jeffrey Lieberman. He teaches at the Vagelos College of Physicians and Surgeons, part of Columbia University, where he studies the treatment of mental illness. His research […]
AP.com | As investors pile into psychedelics, idealism gives way to pharma economics
Money is pouring into the fledgling psychedelic medicine industry, with dozens of startup companies vying to be among the first to sell mind-expanding drugs for depression, addiction and other mental health conditions. While psychedelics are still illegal under federal law, companies are jostling to try […]
